Get the app
US › Healthcare

MapLight Therapeutics, Inc. Common Stock (MPLT)

US · Healthcare · Biotechnology

$7.70-3.99%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-60.2M
EPS
$-1.32
EPS estimate
$-1.40

EPS came in at -1.32 against a street estimate of -1.40 — a beat of 5.7%.

Key statistics

Market cap
$437.7M
Forward P/E
0.0
P/B
1.74
Book value
$7.67
EPS (TTM)
$-6.25
52-week high
$40.43
52-week low
$7.46
50-day MA
$11.61
200-day MA
$21.20

Analyst view

Analysts rate MapLight Therapeutics, Inc. Common Stock a strong buy (12 buy, 3 hold, 0 sell out of 15) with an average price target of $26.54.

Shareholding

Insiders
52.28%
Institutions
48.80%

Largest institutional holders

FundStake
Novo A/S6.63%
FCPM III SERVICES BV5.81%
T. Rowe Price Investment Management,Inc.5.01%
The Goldman Sachs Group Inc3.51%
T. Rowe Price Associates, Inc.2.56%
BlackRock Inc1.84%
Nan Fung Group Holdings Ltd1.75%
5AM Venture Management, LLC1.71%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for MapLight Therapeutics, Inc. Common Stock — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.